Aclaris Therapeutics, Inc. (ACRS)
NASDAQ: ACRS · Real-Time Price · USD
3.030
-0.070 (-2.26%)
Mar 5, 2026, 10:23 AM EST - Market open
Aclaris Therapeutics Stock Forecast
Stock Price Forecast
The 4 analysts with 12-month price forecasts for Aclaris Therapeutics stock have an average target of 9.75, with a low estimate of 6.00 and a high estimate of 16. The average target predicts an increase of 221.78% from the current stock price of 3.03.
Analyst Consensus: Strong Buy
* Price targets were last updated on Jan 28, 2026.
Analyst Ratings
The average analyst rating for Aclaris Therapeutics stock from 5 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Oct '25 | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 1 | 1 | 1 |
| Buy | 6 | 6 | 6 | 4 | 4 | 4 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 9 | 9 | 9 | 5 | 5 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $16 | Strong Buy | Reiterates | $16 | +428.05% | Jan 28, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $16 | Strong Buy | Reiterates | $16 | +428.05% | Jan 21, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $16 | Strong Buy | Reiterates | $16 | +428.05% | Oct 20, 2025 |
| Piper Sandler | Piper Sandler | Buy Initiates $6 | Buy | Initiates | $6 | +98.02% | Jul 10, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $16 | Strong Buy | Reiterates | $16 | +428.05% | Jun 25, 2025 |
Financial Forecast
Revenue This Year
5.14M
from 7.83M
Decreased by -34.31%
Revenue Next Year
4.30M
from 5.14M
Decreased by -16.40%
EPS This Year
-0.66
from -0.53
EPS Next Year
-0.70
from -0.66
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 10.5M | 8.2M | |||
| Avg | 5.1M | 4.3M | |||
| Low | n/a | n/a |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 34.2% | 59.3% | |||
| Avg | -34.3% | -16.4% | |||
| Low | - | - |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | -0.51 | -0.47 | |||
| Avg | -0.66 | -0.70 | |||
| Low | -0.85 | -0.76 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | - | - | |||
| Avg | - | - | |||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.